We are live on ! Find out more
MIM

Martin Investment Management Portfolio holdings

AUM $300M
1-Year Est. Return 6.05%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+6.05%
3 Year Est. Return
+44.71%
5 Year Est. Return
+50.94%
10 Year Est. Return
+276.43%
AUM
$557M
AUM Growth
+$31.6M
Cap. Flow
+$1.17M
Cap. Flow %
0.21%
Top 10 Hldgs %
43.3%
Holding
54
New
7
Increased
20
Reduced
17
Closed
5

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$5.01M
2
NOV icon
NOV
NOV
+$1.87M
3
DRI icon
Darden Restaurants
DRI
+$650K
4
WTW icon
Willis Towers Watson
WTW
+$583K
5
MMM icon
3M
MMM
+$332K

Sector Composition

Rank Sector Weight
1 Healthcare 23.22%
2 Energy 18.26%
3 Technology 17.26%
4 Financials 12.15%
5 Industrials 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.94T
$31.7M 5.69%
1,364,160
-2,492
-0.2% -$53K
HP icon
2
Helmerich & Payne
HP
$3.37B
$27.4M 4.92%
235,945
-2,965
-1% -$325K
GILD icon
3
Gilead Sciences
GILD
$163B
$25.6M 4.59%
308,160
+55
+0% +$4.28K
MA icon
4
Mastercard
MA
$488B
$25M 4.49%
340,268
+2,551
+0.8% +$190K
CELG
5
DELISTED
Celgene Corp
CELG
$24.4M 4.38%
283,898
+1,246
+0.4% +$94.8K
TMO icon
6
Thermo Fisher Scientific
TMO
$207B
$22.4M 4.02%
189,898
-255
-0.1% -$30K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.01T
$22M 3.94%
759,239
-2,204
-0.3% -$59.8K
ORCL icon
8
Oracle
ORCL
$345B
$21.7M 3.89%
534,913
-2,903
-0.5% -$119K
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.07T
$21.2M 3.8%
167,187
+81
+0% +$10.3K
MMM icon
10
3M
MMM
$91.5B
$20M 3.59%
167,213
-2,826
-2% -$332K
FISV
11
Fiserv Inc
FISV
$27.9B
$19.9M 3.57%
659,064
-8,518
-1% -$253K
JNJ icon
12
Johnson & Johnson
JNJ
$643B
$19.8M 3.56%
189,354
+192
+0.1% +$19.4K
SYK icon
13
Stryker
SYK
$129B
$19.3M 3.46%
228,654
+78
+0% +$6.37K
NOV icon
14
NOV
NOV
$7.39B
$19.2M 3.44%
232,719
-25,043
-10% -$1.87M
AXP icon
15
American Express
AXP
$229B
$18.9M 3.39%
198,799
-824
-0.4% -$74.3K
OMC icon
16
Omnicom Group
OMC
$23.5B
$18.8M 3.37%
263,532
-505
-0.2% -$35.2K
VAR
17
DELISTED
Varian Medical Systems, Inc.
VAR
$17.7M 3.18%
243,305
+204
+0.1% +$14.7K
CL icon
18
Colgate-Palmolive
CL
$73.6B
$17.7M 3.17%
259,350
+530
+0.2% +$35.5K
XOM icon
19
ExxonMobil
XOM
$641B
$17.5M 3.14%
173,719
+1,364
+0.8% +$138K
RTX icon
20
RTX Corp
RTX
$296B
$17.1M 3.07%
235,696
-1,998
-0.8% -$147K
CVX icon
21
Chevron
CVX
$379B
$16.8M 3.02%
128,715
+1,364
+1% +$170K
PG icon
22
Procter & Gamble
PG
$347B
$16.3M 2.93%
207,865
+1,860
+0.9% +$150K
VRSK icon
23
Verisk Analytics
VRSK
$27.1B
$14.1M 2.52%
234,298
+522
+0.2% +$31.2K
ABT icon
24
Abbott
ABT
$182B
$13.3M 2.39%
326,023
+668
+0.2% +$26.2K
DVN icon
25
Devon Energy
DVN
$49.9B
$12.6M 2.26%
158,319
+229
+0.1% +$16.7K

Similar funds

Martin Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Martin Investment Management held 54 positions worth $557M, up 6% from $526M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Martin Investment Management's Q2 2014 filing shows 7 new, 20 increased, 17 reduced and 5 closed positions. Its largest new stake was Eaton Vance Corp.: 179,195 shares worth $6.77M. The largest sale was Labcorp, an estimated $5.01M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Energy and Technology.

  • Martin Investment Management's largest Q2 2014 buy was Eaton Vance Corp.: 179,195 shares worth $6.77M.
  • Martin Investment Management added most to SLB Ltd in Q2 2014, an estimated $1.27M increase.
  • Martin Investment Management's biggest Q2 2014 reduction was Labcorp, cutting an estimated $5.01M.
  • Martin Investment Management fully exited Darden Restaurants in Q2 2014, selling an estimated $650K.
  • Martin Investment Management's ten largest holdings make up 43% of its $557M portfolio in Q2 2014.
  • Martin Investment Management opened 7 new positions and closed 5 in Q2 2014.
  • Martin Investment Management's portfolio value rose 6% quarter-over-quarter to $557M.

Based on Martin Investment Management's 13F filing for Q2 2014, filed 29 Jul 2014.